SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Slemmer who wrote (1754)5/29/1997 6:00:00 PM
From: Edderd   of 3991
 
Rick,
I've been having a few good laughs reading this thread (my first). Just to add to the unsubstantiated info I again state that almost all of the urologists I talk to have a good response to the use of MUSE. Saw two GU guys from S. GA today who said 50% refill rate. Can't get the 250 dose. I still think they VIVUS did not understand the extent of the impotence problem and the potential market. I dont think most people on this thread have any real idea how enormous the market will be. With VIVUS increasing their production facilities by 15 to 20 times within the next year their success is almost garaunteed. Sooner or later fundamentals will take over. You might be able to predict this with your charting. I wish you good luck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext